
Rima McLeod
Medical Director, Toxoplasmosis Center · Pritzker School of Medicine
Credentials: · · ·
History
- Present
Toxoplasmosis Center · Pritzker School of Medicine
- Present
- 2022–2024
Infectious Disease
Research
Evidence for the shikimate pathway in apicomplexan parasites
Nature · 1998 · Last of 12 authors · 353 citations
Review · Molecular and Biochemical Parasitology · 2003 · 228 citations
Clinical Infectious Diseases · 2006 · First of 16 authors · Corresponding · 204 citations

36 papers
- JR
24 papers
- CS
21 papers
- PR
20 papers

19 papers · 15 as a resident
- AN
17 papers
- NR
17 papers

16 papers
Grants
- 2009–2015
Optimizing Inhibitors of T. gondii ENR
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $4.4M · University of Chicago
- 2008–2014
Towards a Vaccine to Prevent Toxoplasmosis
National Institute of Allergy and Infectious Diseases · U01
Contact PI · $4.2M · University of Chicago
- 1989–2013
Treatment of Congenital Toxoplasmosis
National Institute of Allergy and Infectious Diseases · R01
Contact PI · $5.5M · University of Chicago
- 2010–2012
Comprehensive Biology: Exploiting the Yeast Genome
National Center for Research Resources · P41
Project lead · $15.2K · University of Washington
Clinical trials
- 2020–2026
Point of Care Testing for Presence of Current and or Previous T. Gondii Infection
Principal investigator · Recruiting
University of Chicago
- 2000–2030
Pyrimethamine, Sulfadiazine, and Leucovorin in Treating Patients With Congenital Toxoplasmosis
Study chair · Recruiting · Phase 4
National Institute of Allergy and Infectious Diseases (NIAID)

